興源環境(300266.SZ):子公司中標2.496億元的製漿造紙污水處理改造EPC項目
格隆匯1月12日丨興源環境(300266.SZ)公佈,公司全資子公司浙江水美環保工程有限公司(“浙江水美”)於近日收到《山東博彙紙業股份有限公司-製漿造紙污水處理改造EPC項目中標通知書》,確認浙江水美為該項目供應商。
該項目總價為人民幣2.496億元(未税),佔公司2020年度經審計營業收入的 10.19%。該項目中標體現了浙江水美在工業污水處理領域的競爭優勢和技術優勢、項目設計能力以及執行能力。若該中標項目能夠簽訂正式項目合同並順利實施,將對公司經營業績產生積極影響。該項目不會對公司的業務獨立性產生重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.